Vermillion Announces Appointment of John Hamilton to Board of Directors

... FREMONT Calif. April 10 /- Vermillion In... John brings more than 20 years of active board-level engagement onfi...Mr. Hamilton began his career in the banking industry and went on toh...Mr. Hamilton's appointment to Vermillion's board of directors went int...

FREMONT, Calif., April 10 /PRNewswire-FirstCall/ -- Vermillion, Inc.
(Nasdaq: VRML), a molecular diagnostics company, today announced the
appointment of John F. Hamilton to its board of directors. Mr. Hamilton is
the former vice president and chief financial officer of Depomed, Inc., a
specialty pharmaceutical company.

"John brings more than 20 years of active board-level engagement on
financial, strategic and audit matters to Vermillion. His solid experience
working with small to mid-size companies in the healthcare sector is a
perfect fit with our business model," said Gail Page, President and CEO of
Vermillion. "We are pleased to welcome John to the board, especially at
such an exciting time in the company's evolution as we prepare to
commercialize several of our diagnostic tests later this year. His
financial savvy and analytical approach will prove invaluable to the
Company."

Mr. Hamilton began his career in the banking industry and went on to
hold senior financial positions at several biopharmaceutical companies
including Glyko, Inc. -- now BioMarin Pharmaceuticals -- and Chiron
Corporation. He sits on the regional board of directors of the Association
of Bioscience Financial Officers and is past-president of the Treasurers
Club of San Francisco. Mr. Hamilton received his M.B.A. from the University
of Chicago and his B.A. in International Relations from the University of
Pennsylvania.

Mr. Hamilton's appointment to Vermillion's board of directors went into
effect on April 9, 2008. Additionally, Mr. Hamilton will serve as chairman
of the Company's audit committee. He will replace Judy Bruner, executive
vice president of administration and chief financial officer of SanDisk
Corporation, who resigned from the board of directors on April 8, 2008.

"We would like to thank Judy for her leadership, expertise and
contributions as a board member," said Page. "She has added significant
value to Vermillion for the past 5 years and we wish her well in her future
endeavors."

About Vermillion

Vermillion, Inc. is dedicated to the discovery, development and
commercialization of novel high-value diagnostic tests that help physicians
diagnose, treat and improve outcomes for patients. Vermillion, along with
its prestigious scientific collaborators, has diagnostic programs in
oncology, hematology, cardiology and women's health. Vermillion is based in
Fremont, California. Additional information about Vermillion can be found
on the Web at http://www.vermillion.com.

Forward Looking Statement:

This news release contains forward-looking statements that involve
significant risks and uncertainties, including statements regarding
Vermillion's plans, objectives, expectations and intentions and the risks
and uncertainties discussed in Vermillion's latest Form 10-K and
Vermillion's periodic reports on Form 10-Q and Form 8-K. These
forward-looking statements are based on Vermillion's current expectations.
Vermillion is providing this information as of the date of this news
release and does not undertake any obligation to update any forward-looking
statements as a result of new information, future events or otherwise.
Forward-looking statements cannot be guaranteed and actual results may
differ materially from Vermillion's current expectations. You are
encouraged to read Vermillion's reports filed with the U.S. Securities and
Exchange Commission, available at http://www.sec.gov.

(Date:12/9/2016)... , December 9, 2016 According to ... Services (Primer, Probe, Custom, Predesigned, Reagent Equipment), Application (Research, PCR, Gene, ... to 2021" published by MarketsandMarkets, the global market is expected to ... 2016, at a CAGR of 10.6% during the forecast period. ... ...

(Date:12/8/2016)... Philadelphia, PA (PRWEB) , ... December 08, 2016 ... ... fan engagement platforms, the business of innovation is taking over sports. On Thursday, ... executive will explore how technology is disrupting the playing field at a Smart ...

(Date:12/6/2016)... -- Valencell , the leading innovator in performance ... third consecutive year of triple digit growth for its ... a 360 percent increase in companies who have acquired ... by sales of its wrist and ear Benchmark™ sensor ... for hearables for fitness and healthcare applications. ...

(Date:11/30/2016)... , Nov. 30, 2016 higi SH llc ... partnership initiative targeting national brands, industry thought-leaders and ... their respective audiences for taking steps to live ... inception in 2012, higi has built the largest ... over 38 million people who have conducted over ...